Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Bdh1em1flox/Cya
Common Name:
Bdh1-flox
Product ID:
S-CKO-15257
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Bdh1-flox
Strain ID
CKOCMP-71911-Bdh1-B6J-VA
Gene Name
Bdh1
Product ID
S-CKO-15257
Gene Alias
2310032J20Rik; Bdh
Background
C57BL/6JCya
NCBI ID
71911
Modification
Conditional knockout
Chromosome
16
Phenotype
MGI:1919161
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Bdh1em1flox/Cya mice (Catalog S-CKO-15257) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000115227
NCBI RefSeq
NM_001122683
Target Region
Exon 3~4
Size of Effective Region
~2.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Bdh1, short for β -hydroxybutyrate dehydrogenase 1, is the rate -limiting enzyme in ketone metabolism. It plays a critical role in the conversion between acetoacetate and β -hydroxybutyrate [1,3,4,5]. The presence of β -hydroxybutyrate is essential for initiating lysine β -hydroxybutyrylation (Kbhb) modifications, and histone Kbhb at the H3K9 site is related to transcriptional activation [1]. Bdh1 is involved in various biological processes and diseases, highlighting its biological importance. Genetic models, such as gene knockout mouse models, can be used to study its functions.

In striated muscles, Bdh1 deficiency in mice reveals that this enzyme optimizes fatty acid oxidation (FAO) efficiency and exercise tolerance during acute fasting. Also, muscle Bdh1 flux is crucial for the full adaptive benefits of intermittent time -restricted feeding (iTRF), including increased lean mass, mitochondrial hormesis, and metabolic rerouting of pyruvate [2].

In the context of diseases, in diabetic kidney disease (DKD), Bdh1 is downregulated in the kidneys of DKD mouse models, patients with diabetes, and high-glucose-or palmitic acid-induced human renal tubular epithelial cells. Overexpression of Bdh1 in C57 BKS db/db mice can reverse fibrosis, inflammation, and apoptosis in the kidneys [3]. In diabetic cardiomyopathy, genetic deletion of Bdh1 in mice aggravated, while AAV-mediated Bdh1 overexpression attenuated, the diastolic dysfunction and pathogenic progression in hearts from db/db mice [4]. In acute myeloid leukemia (AML), overexpression of Bdh1 in AML cell lines inhibited cell viability and proliferation, while Bdh1 knock-down promoted cell growth, and low Bdh1 expression was associated with worse prognosis in AML patients [7]. Ablation of Bdh1 in T cells of mice aggravated the manifestation of metabolic dysfunction-associated steatohepatitis (MASH) and hindered the therapeutic efficacy of empagliflozin [6].

In summary, Bdh1 is a key enzyme in ketone metabolism with important functions in maintaining normal physiological states of muscles and preventing the progression of various diseases like DKD, diabetic cardiomyopathy, AML, and MASH. The use of gene knockout or conditional knockout mouse models has significantly contributed to understanding the role of Bdh1 in these biological processes and disease conditions, providing potential therapeutic targets for these diseases.

References:
1. Huang, Jingjing, Liang, Lu, Jiang, Shiyao, Cong, Li, Jiang, Yiqun. 2023. BDH1-mediated LRRC31 regulation dependent on histone lysine β-hydroxybutyrylation to promote lung adenocarcinoma progression. In MedComm, 4, e449. doi:10.1002/mco2.449. https://pubmed.ncbi.nlm.nih.gov/38098610/
2. Williams, Ashley S, Crown, Scott B, Lyons, Scott P, Zhang, Guo-Fang, Muoio, Deborah M. . Ketone flux through BDH1 supports metabolic remodeling of skeletal and cardiac muscles in response to intermittent time-restricted feeding. In Cell metabolism, 36, 422-437.e8. doi:10.1016/j.cmet.2024.01.007. https://pubmed.ncbi.nlm.nih.gov/38325337/
3. Wan, Sheng-Rong, Teng, Fang-Yuan, Fan, Wei, Jiang, Zong-Zhe, Xu, Yong. 2023. BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway. In Aging, 15, 13384-13410. doi:10.18632/aging.205248. https://pubmed.ncbi.nlm.nih.gov/38015723/
4. Xu, Bu-Tuo, Wan, Sheng-Rong, Wu, Qi, Xu, Yong, Jiang, Zong-Zhe. 2025. BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2. In Cardiovascular diabetology, 24, 101. doi:10.1186/s12933-025-02646-3. https://pubmed.ncbi.nlm.nih.gov/40022118/
5. Xu, Bu-Tuo, Teng, Fang-Yuan, Wu, Qi, Xu, Yong, Jiang, Zong-Zhe. 2022. Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model. In Cell death discovery, 8, 49. doi:10.1038/s41420-022-00840-w. https://pubmed.ncbi.nlm.nih.gov/35115498/
6. Liu, Wenhui, You, Danming, Lin, Jiayang, Yang, Wei, Zhang, Huijie. 2024. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation. In Cell metabolism, 36, 2245-2261.e6. doi:10.1016/j.cmet.2024.08.005. https://pubmed.ncbi.nlm.nih.gov/39243758/
7. Han, Fei, Zhao, Huanhuan, Lu, Jun, Wang, Qishan, Jiang, Xi. 2021. Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia. In Frontiers in oncology, 11, 694594. doi:10.3389/fonc.2021.694594. https://pubmed.ncbi.nlm.nih.gov/34150668/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest